Corporate Profile
Corporate History
In April 1946, Otojiro Shibata of Shibata Pharmacy (Suita City, Osaka Prefecture, since July 1940), founder of Taiko Pharmaceutical, acquired the right of manufacture and sell Chuyu-Seirogan which was given by Osaka Prefecture to Saichi Nakajima in 1902.
Chronicle of Taiko Pharmaceutical
| 1946 Nov | Otojiro Shibata established Taiko Pharmaceutical Co., Ltd.in Suita City, Osaka, Japan, with a launch of CHUYU SEIROGAN (current SEIROGAN.) |
|---|---|
| 1954 May | Started the export of SEIROGAN to other countries. |
| 1964 Apr | The Tokyo Branch was established. |
| 1966 Oct | SEIROGAN TOI, a sugar coated tablet, was introduced to the market. |
| 1972 Jun | The headquarters and factory in Suita City, Osaka, were completed. |
| 1979 Jun | The factory was remodelled to meet the GMP requirements. (*1) |
| 1981 Nov | SEIROGAN TOI A, a sugar coated tablet, was introduced to the market. |
| 1990 Nov | The Nagoya Branch was established. |
| 1991 Nov | The expansion of the factory and R&D building at the headquarters in Suita City, Osaka, was completed. |
| 1992 Mar | Taiko Creosote Co., Ltd., (current Taiko TEC Co., Ltd.) was established in Suita City, Osaka, to produce wood creosote. |
| 1996 Dec | Established Taiko Pharmaceutical Co., Ltd. (TAIWAN) in Taiwan to strengthen sales of pharmaceuticals in the Taiwanese market. |
| 1997 Feb | The Shenzhen Office was established in China to conduct a market research and gather pharmaceutical information. |
| 2004 Nov | Taiko Pharmaceutical (Asia Pacific) Co., Ltd. was established, (now an affiliate of Taiko Pharmaceutical) for the sales and pharmaceutical businesses in Hong Kong and China. |
| 2005 Feb | Seirogan (International) Co., Ltd. was established in Hong Kong. |
| 2005 Apr | Cleverin was launched. |
| 2005 Nov | To promote the infection control business, Taiko Pharmaceutical acquired the ownership of Abe Environmental Technologies (Shanghai) Co., Ltd., a sanitation control product manufacturer. As a consolidated subsidiary, the company changed its name to Taiko Abe Environmental Technologies (Shanghai) Co., Ltd. (the current consolidated subsidiary of Taiko Environmental Technologies (Shanghai) Co., Ltd.) |
| 2006 Mar | Merged with Business Plan Inc. to expand the infection control business |
| 2009 Mar | Listed on the second section of Tokyo Stock Exchange |
| 2010 Apr | Listed on the first section of Tokyo Stock Exchange |
| 2011 Dec | The Tokyo Office was moved to new office. |
| 2012 Feb | Established Taiko Pharmaceuticol Co., Ltd Taiwan Branch |
| 2013 Mar | The Nagoya Office was moved to new office. |
| 2014 Mar | The Headquaters was moved to Nishi-Honmachi, Nishi-ku, Osaka. |
| 2015 Aug | The Kyoto Plant/R&D Center was established. |
| 2017 Apr | Launched "Seirogan Quick C" |
| 2019 Sep | Launched “Cleve & And,” a new brand of daily sterilization products |
| 2020 Apr | Established Taiwan Taiko Pharmaceutical Co., Ltd. in Taiwan with a Cleverin-related EC business transferred from a local sales distributor |
| 2020 May | Established Taiko Pharmaceutical (Shenzhen) Co., Ltd. in Shenzhen expand both the pharmaceutical business and the infection control business in China |
| 2020 Oct | Established Taiko Pharmaceutical International Co., Ltd. in Nishi-ku, Osaka |
| 2020 Nov | Established the Ibaraki Plant in Saito, Ibaraki, Osaka |
| 2021 Jan | Closed the Shenzhen Office for integration with Taiko Pharmaceutical (Shenzhen) Co., Ltd. |
| 2021 Oct | Closed the Taiwan Office for integration with Taiwan Taiko Pharmaceutical Co., Ltd. |
| 2022 Apr | Moved to the Prime Market of Tokyo Stock Exchange |
*1. GMP -certified factory
Good Manufacturing Practice (GMP) is a standard for maintaining the quality of pharmaceuticals during the manufacturing stage. In Japan, manufacturing
facilities that comply with the manufacturing and quality-control standards stipulated by the Ministry of Health, Labor and Welfare (MHLW) ordinance
(Ministerial Ordinance on Standards for Manufacturing Control and Quality Control of Drugs, Quasi-drugs (MHLW Ordinance 179 of 24 December 2004)),
which is based on the Pharmaceutical and Medical Device Act (PMD Act); former the Pharmaceutical Affairs Act, are generally called “GMP-certified factory.”
